Culmination Bio Inc

Our mission is to discover better health by unlocking biological data and enriching it with clinical, claims, and omics-level data.

[Culmination Bio Inc @Culminationbio]

CEO, Lincoln Nadauld, sat down w/ @dslevine on The Bio Report to discuss how real-world data is transforming drug discovery & clinical trials. Tune in to learn how Culmination Bio’s 40+ years of data is driving healthcare innovation:https://t.co/xpmxvgYzrl

[Culmination Bio Inc @Culminationbio]

"To have clinical, genomic, and biospecimen data, all linked in a continuous fashion over decades, & from a single source, is unusual."
CEO Lincoln Nadauld sat down w/ @Merck @IyaKhalil to talk unusual data for understanding biology in @DrugDiscoverDev : https://t.co/SmFUbBtaYP

[Culmination Bio Inc @Culminationbio]

Currently, 1 in 5 people develop cancer in their lifetime.

To better understand cancer and make care determinations, @BillionToOneInc is developing and validating diagnostics with Culmination Bio’s extensive patient base. More via HIT Consultant: https://t.co/R9g4bVbaoQ

[Culmination Bio Inc @Culminationbio]

In a 24-month R&D partnership, @Merck is leveraging our unique ability to build retrospective and prospective deidentified multi-modal datasets to study a variety of autoimmune diseases.

More details from Joesph Keenan in @FierceBiotech: https://t.co/wEBHsmErGC

CC: @AGKootenay

[Culmination Bio Inc @Culminationbio]

��To Lincoln Nadauld, the $10 million raised by his fledgling company Culmination Bio in its first financing round is market validation of the industry-wide need for detailed, longitudinal data…”

More from @Ch_Hops in Precision Medicine Online: https://t.co/aJb0yWOFcp

[Culmination Bio Inc @Culminationbio]

Now backed with $10 million from @Amgen and @Merck, we’re building the largest disease-agnostic patient data intelligence platform to solve the data gap in pharma. Read about our patient data repository from @erinbrodwin via @axios: https://t.co/Ujt99mRmje

[Culmination Bio Inc @Culminationbio]

We're excited to announce that Dr. Lincoln Nadauld will be speaking at the Illumina Genomics Forum alongside other experts in discussing the use of genomics to advance precision health. Dr. Nadauld will be speaking on the power of multimodal data for healthcare innovation.